PGNX - Progenics Pharmaceuticals EPS beats by $0.12 beats on revenue March, 13 2020 08:37 AM Progenics Pharmaceuticals Inc. Progenics Pharmaceuticals (NASDAQ:PGNX): Q4 GAAP EPS of -$0.13 beats by $0.12.More news on: Progenics Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...